500 patients67,039 observations150 daysLIVE

Patient P-03405

Synthetic patientONX-7 · Day 105 · 75+ · M · baseline S16Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
62%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S16

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+19
  • Toxicity+19
  • Inflammatory activity+18
  • Nutritional resilience-14
  • Treatment adherence-12

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    62%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 81% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    4.7/10
    worsening · -0.9 vs previous 14 d
    Stress level
    Daily log
    5.8/10
    worsening · +1.2 vs previous 14 d
    Pessimism score
    Daily log
    5/10
    worsening · +0.6 vs previous 14 d
    Sleep quality
    Wearable
    56.3/100
    worsening · -3.6 vs previous 14 d
    Libido
    Daily log
    3.1/10
    worsening · -0.8 vs previous 14 d
    HRV
    Wearable
    58.1 ms
    worsening · -3.4 vs previous 14 d
    Toxicity
    Blood
    33.9/100
    worsening · +9.1 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 45 from the failing basin, 47 from restoration.

    Would help
    • GI-04 GI Support Protocol
      82% improved among 28 similar · onset 8 d · confidence 61%
    • DT-01 Dosing / Timing Recommendation
      83% improved among 12 similar · onset 5 d · confidence 71%
    • ME-01 Monitoring Escalation
      100% improved among 6 similar · onset 3 d · confidence 71%
    • More protein
      GI -8.2 next day on high-intake days · n 16
    Would not help
    • Keep fat low
      GI +7.4 next day on high-intake days · n 25
    • Keep lactose low
      GI +6.6 next day on high-intake days · n 22
    • Keep histamine low
      GI +6 next day on high-intake days · n 23
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -8.2supporter · 95%
    • Dietary fat load
      +7.4detractor · 95%
    • Lactose
      +6.6detractor · 95%
    • Histamine load
      +6detractor · 95%
    • Alcohol
      +3.8detractor · 67%
    • Caffeine
      +1.3no signal · 23%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 80
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 53 and rising
    • Inflammatory signalling 70
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 50
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 28/100
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 25
      • WearableResting HR 74 bpm
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.2 · butyrate capacity 28/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    54 ms
    Sleep
    7.4 h
    Steps
    6,555
    Resting HR
    68 bpm
    Daily log: GI score 53, nutritional resilience 45, adherence 88.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0307438%S0160
    P-0338236%S01GI-04improved56
    P-0338933%S0150
    P-0344332%S0152
    P-0309231%S0161
    P-0325531%S01HY-01improved53
    P-0338130%S0155
    P-0338426%S0155
    P-0317725%S0128
    P-0301424%S0132
    P-0324537%S0257
    P-0330132%S0262